Company logo

LIN - Linde plc

XETRA -> Basic Materials -> Specialty Chemicals
Guildford, United Kingdom
Type: Equity

LIN price evolution
LIN
(in millions $) 31 Jan 2024 30 Oct 2023 30 Jul 2023 1 May 2023
Current assets
Cash
Short term investments
Net receivables $4914 $4843 $4955 $4928
Inventory $2115 $2078 $2079 $2054
Total current assets $12620 $11737 $11411 $12904
Long term investments
Property, plant & equipment $24552 $23624 $23808 $23796
Goodwill & intangible assets
Total noncurrent assets
Total investments
Total assets $80811 $77827 $78718 $80308
Current liabilities
Accounts payable $3020 $2750 $2977 $2941
Deferred revenue
Short long term debt
Total current liabilities $15717 $14162 $14552 $17785
Long term debt $13397 $13232 $13528 $11744
Total noncurrent liabilities
Total debt
Total liabilities $41091 $38929 $38807 $40338
Shareholders' equity
Retained earnings $8845 $7940 $7024 $6092
Other shareholder equity -$5805 -$6676 -$5899.49 -$5810.49
Total shareholder equity
(in millions $) 31 Jan 2024 31 Jan 2023 31 Jan 2022 30 Dec 2020
Current assets
Cash $2823 $3754
Short term investments
Net receivables $4914 $4683 $4633 $4590
Inventory $2115 $1978 $1733 $1729
Total current assets $12620 $13047 $10159 $10924
Long term investments $2637 $2084
Property, plant & equipment $24552 $23548 $27019 $29801
Goodwill & intangible assets
Total noncurrent assets $77305
Total investments
Total assets $80811 $79658 $81605 $88229
Current liabilities
Accounts payable $3020 $2995 $3503 $3095
Deferred revenue
Short long term debt $1709 $751
Total current liabilities $15717 $16479 $13643 $13740
Long term debt $13397 $12198 $11335 $12152
Total noncurrent liabilities $24920
Total debt
Total liabilities $41091 $39630 $37570 $38647
Shareholders' equity
Retained earnings $8845 $20541 $18710 $17178
Other shareholder equity -$5805 -$5782 -$5048 -$4690
Total shareholder equity $44035 $47317
(in millions $) 31 Jan 2024 30 Oct 2023 30 Jul 2023 1 May 2023
Revenue
Total revenue $8302 $8193
Cost of revenue
Gross Profit $3871 $3762
Operating activities
Research & development
Selling, general & administrative
Total operating expenses $1845 $1811
Operating income
Income from continuing operations
EBIT
Income tax expense $459 $430
Interest expense -$71 -$37
Net income
Net income $1543 $1516
Income (for common shares)
(in millions $) 31 Jan 2024 31 Jan 2023 30 Dec 2021 30 Dec 2020
Revenue
Total revenue $33364 $30793 $27243
Cost of revenue $17543 $15383
Gross Profit $13914 $13250 $11860
Operating activities
Research & development $143 $152
Selling, general & administrative $2997 $3016
Total operating expenses $7494 $25292 $23137
Operating income $5501 $4106
Income from continuing operations
EBIT $5501 $4106
Income tax expense $1434 $1262 $847
Interest expense -$98 -$170 -$239
Net income
Net income $4147 $3826 $2501
Income (for common shares) $3826 $2501
(in millions $) 31 Jan 2024 30 Oct 2023 30 Jul 2023 1 May 2023
Net income
Operating activities
Depreciation
Business acquisitions & disposals
Stock-based compensation
Total cash flows from operations
Investing activities
Capital expenditures
Investments
Total cash flows from investing -$4670 -$3444 -$2498 -$1634
Financing activities
Dividends paid -$2482 -$1866 -$1246 -$623
Sale and purchase of stock
Net borrowings
Total cash flows from financing -$5400 -$4620 -$3656 -$764
Effect of exchange rate -$7 -$56 $17 $16
Change in cash and equivalents -$772 -$1542 -$2079 -$474
(in millions $) 31 Jan 2024 31 Jan 2023 30 Dec 2021 30 Dec 2020
Net income $3826 $2501
Operating activities
Depreciation $4635 $4626
Business acquisitions & disposals
Stock-based compensation
Total cash flows from operations $9725 $7429
Investing activities
Capital expenditures -$3086 -$3400
Investments
Total cash flows from investing -$4670 -$3088 -$3007 -$2986
Financing activities
Dividends paid -$2482 -$2344 -$2189 -$2028
Sale and purchase of stock
Net borrowings -$514 $1313
Total cash flows from financing -$5400 -$3089 -$7588 -$3345
Effect of exchange rate -$7 -$74 -$61 -$44
Change in cash and equivalents -$772 $2613 -$931 $1054
Fundamentals
Market cap $200.36B
Enterprise value N/A
Shares outstanding 484.89M
Revenue N/A
EBITDA N/A
EBIT N/A
Net Income N/A
Revenue Q/Q 5.10%
Revenue Y/Y N/A
P/E ratio N/A
EV/Sales N/A
EV/EBITDA N/A
EV/EBIT N/A
P/S ratio N/A
P/B ratio N/A
Book/Share N/A
Cash/Share N/A
EPS N/A
ROA N/A
ROE N/A
Debt/Equity N/A
Net debt/EBITDA N/A
Current ratio 0.80
Quick ratio 0.67